Knight Therapeutics Inc News

Knight Therapeutics Announces Regulatory Approval of TAVALISSE in Mexico

GlobeNewswireDec 12 07:30 ET

Knight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 9 06:53 ET · Conference Call

Knight Therapeutics Inc (KHTRF) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Margin ...

InvestingNov 7 20:14 ET

Express News | Knight Therapeutics Announces Approval of Minjuvi® (Tafasitamab) in Mexico

ReutersOct 15 08:30 ET

Knight Therapeutics Announces Approval of Minjuvi (Tafasitamab) in Mexico

GlobeNewswireOct 15 08:30 ET

Knight Therapeutics Inc. Places No. 397 on The Globe and Mail's Sixth Annual Ranking of Canada's Top Growing Companies

GlobeNewswireSep 27 10:22 ET

Knight Therapeutics Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now

Yahoo FinanceAug 11 09:03 ET

Earnings Flash: Knight Therapeutics Q2 Revenue $95.5 Million, Up 6% From 2023

MT NewswiresAug 8 07:41 ET

Knight Therapeutics Brief: Delivered Record Revenues of $95.573 Million, an Increase of 6% Over the Same Period in Prior Year

MT NewswiresAug 8 07:36 ET

Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call

GlobeNewswireAug 1 07:30 ET

Knight Therapeutics Inc. (TSE:GUD) Stock Most Popular Amongst Individual Investors Who Own 40%, While Private Companies Hold 25%

Yahoo FinanceJul 13 10:06 ET

Knight Therapeutics Inc: INTERIM MDA FR

SEDARMay 16 13:10 ET · Announcements

Knight Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT FR

SEDARMay 16 13:08 ET · Announcements

Earnings Call Summary | KNIGHT THERAPEUTICS INC(KHTRF.US) Q1 2024 Earnings Conference

moomoo AIMay 11 15:33 ET · Conference Call

Knight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1

MT NewswiresMay 9 11:02 ET

Knight Therapeutics Inc: INTERIM MDA EN

SEDARMay 9 07:48 ET · Announcements

Knight Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

SEDARMay 9 07:48 ET · Announcements

Knight Therapeutics Brief: Entering Into Exclusive Supply and Distribution Agreement With Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM In Canada and Latin America

MT NewswiresMay 9 07:33 ET

Knight Therapeutics Reports First Quarter 2024 Results

Stockhouse May 9 07:30 ET

Knight Therapeutics Inc. Announces Voting Results From the Annual General Meeting

GlobeNewswireMay 8 18:32 ET